FDA rejects Oral Cladribine for MS

[ActiveMSers]

Concerns about safety, in particular a potential rise of cancer, has this new oral drug still sitting on the shelf. After too-fast approvals that have led to serious consequences, I can see why the FDA is being so cautious and requiring more study....

http://www.medscape.com/viewarticle/738239